Here we found that in CRC TME, TIM-3+ Tregs have higher expression of FoxP3, CD25, Helios, CCR7, and also co-inhibitory molecules including PD-1, CTLA4, and TIM-3 (Figure 2 and Figure S3). The gene discussed is HAVCR2; the disease is colorectal carcinoma.